Rare diseases
Investigational molecules
Locations
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
BulgariaA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
BulgariaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BulgariaA study of navenibart for long-term safety in patients with hereditary angioedema
BulgariaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
BulgariaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
BulgariaA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaA study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania
BulgariaStudy of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight
BulgariaStudy of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
